# A Phase I Study of Oral BGJ398 in Asian Patients

> **NCT01697605** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 9 (actual)

## Conditions studied

- Tumor With Alterations of the FGF-R

## Interventions

- **DRUG:** BGJ398

## Key facts

- **NCT ID:** NCT01697605
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-19
- **Primary completion:** 2019-02-07
- **Final completion:** 2019-02-07
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697605, "A Phase I Study of Oral BGJ398 in Asian Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01697605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*